BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12704399)

  • 1. Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance.
    Nakagawa T; Ogawa Y; Ebihara K; Yamanaka M; Tsuchida A; Taiji M; Noguchi H; Nakao K
    Int J Obes Relat Metab Disord; 2003 May; 27(5):557-65. PubMed ID: 12704399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
    Yamanaka M; Itakura Y; Inoue T; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice.
    Yamanaka M; Itakura Y; Ono-Kishino M; Tsuchida A; Nakagawa T; Taiji M
    J Biosci Bioeng; 2008 Apr; 105(4):395-402. PubMed ID: 18499057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
    Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
    Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice.
    Nakagawa T; Tsuchida A; Itakura Y; Nonomura T; Ono M; Hirota F; Inoue T; Nakayama C; Taiji M; Noguchi H
    Diabetes; 2000 Mar; 49(3):436-44. PubMed ID: 10868966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
    Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
    Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice.
    Nakagawa T; Ono-Kishino M; Sugaru E; Yamanaka M; Taiji M; Noguchi H
    Diabetes Metab Res Rev; 2002; 18(3):185-91. PubMed ID: 12112936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiobesity and antidiabetic effects of biotransformed blueberry juice in KKA(y) mice.
    Vuong T; Benhaddou-Andaloussi A; Brault A; Harbilas D; Martineau LC; Vallerand D; Ramassamy C; Matar C; Haddad PS
    Int J Obes (Lond); 2009 Oct; 33(10):1166-73. PubMed ID: 19687792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy and lactation have anti-obesity and anti-diabetic effects in A(y)/a mice.
    Makarova EN; Yakovleva TV; Shevchenko AY; Bazhan NM
    Acta Physiol (Oxf); 2010 Feb; 198(2):169-77. PubMed ID: 19785628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [D-Leu-4]-OB3 and MA-[D-Leu-4]-OB3, small molecule synthetic peptide leptin mimetics, improve glycemic control in diet-induced obese (DIO) mice.
    Wang A; Anderson BM; Novakovic ZM; Grasso P
    Peptides; 2018 Mar; 101():51-59. PubMed ID: 29269073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.
    Mashiko S; Ishihara A; Iwaasa H; Moriya R; Kitazawa H; Mitobe Y; Ito J; Gomori A; Matsushita H; Takahashi T; MacNeil DJ; Van der Ploeg LH; Fukami T; Kanatani A
    Obesity (Silver Spring); 2008 Jul; 16(7):1510-5. PubMed ID: 18421274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciliary neurotrophic factor restores gallbladder contractility in leptin-resistant obese diabetic mice.
    Graewin SJ; Kiely JM; Svatek CL; Pitt HA
    J Surg Res; 2006 Jan; 130(1):146-51. PubMed ID: 16389100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central infusion of histamine reduces fat accumulation and upregulates UCP family in leptin-resistant obese mice.
    Masaki T; Yoshimatsu H; Chiba S; Watanabe T; Sakata T
    Diabetes; 2001 Feb; 50(2):376-84. PubMed ID: 11272150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome.
    Madsen AN; Hansen G; Paulsen SJ; Lykkegaard K; Tang-Christensen M; Hansen HS; Levin BE; Larsen PJ; Knudsen LB; Fosgerau K; Vrang N
    J Endocrinol; 2010 Sep; 206(3):287-96. PubMed ID: 20508079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice.
    Leinung MC; Grasso P
    Regul Pept; 2012 Nov; 179(1-3):33-8. PubMed ID: 22960403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice.
    Yamanaka M; Tsuchida A; Nakagawa T; Nonomura T; Ono-Kishino M; Sugaru E; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Jan; 9(1):59-64. PubMed ID: 17199719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis.
    Asensio C; Cettour-Rose P; Theander-Carrillo C; Rohner-Jeanrenaud F; Muzzin P
    Endocrinology; 2004 May; 145(5):2206-13. PubMed ID: 14962997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity.
    Pierroz DD; Ziotopoulou M; Ungsunan L; Moschos S; Flier JS; Mantzoros CS
    Diabetes; 2002 May; 51(5):1337-45. PubMed ID: 11978628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor ameliorates lipid metabolism in diabetic mice.
    Tsuchida A; Nonomura T; Nakagawa T; Itakura Y; Ono-Kishino M; Yamanaka M; Sugaru E; Taiji M; Noguchi H
    Diabetes Obes Metab; 2002 Jul; 4(4):262-9. PubMed ID: 12099975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.